The third week of February marks the first doses of the coronavirus vaccine arrived in Australia.
This first shipment is part of 20 million doses of the Pfizer vaccine, secured through an advance purchasing agreement under our vaccine strategy.
The arrival of the vaccine confirms that we are on track for our most vulnerable groups to start receiving the vaccine on 22 February 2021.
Approximately 80,000 doses of the Pfizer vaccine will be made available in the first week.
The first priority for vaccines are hotel quarantine and border workers, frontline healthcare workers and aged care and disability care residents and staff.
The Therapeutic Goods Administration (TGA) has approved the AstraZeneca COVID-19 vaccine for use in Australia following a full and thorough assessment process.
We have secured 53.8 million doses of the AstraZeneca vaccine, with 50 million doses being manufactured here in Australia.
Our nation is one of a small number of countries in the world that can manufacture its own COVID-19 vaccine and that is a point of pride to all around our country.
Data from clinical trials tells us that the AstraZeneca vaccine will stop people becoming seriously unwell with COVID-19. This is – and must – be our first priority. It would be irresponsible of us to put anything ahead of this.
The global evidence is of overwhelming protection against serious illness, hospitalisation and loss of life.
Importantly the TGA has conducted a full and thorough, and world class assessment process.
This means that two safe and effective COVID-19 vaccines are approved for use in Australia.
The Government is committed to providing safe and effective vaccines free to everyone in Australia.
For more information visit: https://www.health.gov.au/ or: https://www.pm.gov.au/media/tga-approves-astrazeneca-covid-19-vaccine